Duality Advisers’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,690
| Closed | -$492K | – | 637 |
|
|
2023
Q1 | $492K | Sell |
6,690
-3,129
| -32% | -$230K | 0.06% | 411 |
|
|
2022
Q4 | $656K | Buy |
+9,819
| New | +$656K | 0.07% | 394 |
|
|
2022
Q3 | – | Sell |
-7,656
| Closed | -$426K | – | 652 |
|
|
2022
Q2 | $426K | Buy |
+7,656
| New | +$426K | 0.04% | 488 |
|